ACCESSION: MSBNK-SMB_Measured-HSA001P0153003
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 102
COMMENT: RAW_SPEC {'19_posi_8577': {'bp': 135939.0, 'sum': 278643.0}, 'BLK02_8157': {'bp': 133867.0, 'sum': 268913.0}, '19_posi_7888': {'bp': 133039.0, 'sum': 278700.0}, '18_posi_8158': {'bp': 132961.0, 'sum': 293363.0}, '8_posi_8599': {'bp': 131641.0, 'sum': 279365.0}, '16_posi_8011': {'bp': 131109.0, 'sum': 279415.0}, '11_posi_8514': {'bp': 130960.0, 'sum': 274790.0}, '12_posi_8309': {'bp': 129779.0, 'sum': 291974.0}, '18_posi_8599': {'bp': 129362.0, 'sum': 275074.0}, '9_posi_8600': {'bp': 129228.0, 'sum': 259437.0}, '10_posi_8537': {'bp': 128688.0, 'sum': 248509.0}, '19_posi_7972': {'bp': 128044.0, 'sum': 260690.0}, '14_posi_8604': {'bp': 126080.0, 'sum': 255807.0}, '14_posi_8162': {'bp': 126047.0, 'sum': 276483.0}, '17_posi_7910': {'bp': 125341.0, 'sum': 268456.0}, '16_posi_8432': {'bp': 124755.0, 'sum': 288584.0}, '16_posi_7926': {'bp': 124056.0, 'sum': 254745.0}, '19_posi_8494': {'bp': 123859.0, 'sum': 261635.0}, '7_posi_8373': {'bp': 123807.0, 'sum': 251318.0}, '2_posi_7886': {'bp': 123771.0, 'sum': 262136.0}, '1_posi_8180': {'bp': 122644.0, 'sum': 253115.0}, '9_posi_8013': {'bp': 121093.0, 'sum': 264400.0}, 'BLK02_7910': {'bp': 121073.0, 'sum': 256088.0}, '16_posi_8181': {'bp': 120925.0, 'sum': 256656.0}, '16_posi_8264': {'bp': 120605.0, 'sum': 262908.0}, '12_posi_7992': {'bp': 120274.0, 'sum': 248461.0}, '15_posi_8600': {'bp': 119753.0, 'sum': 266356.0}, '5_posi_8578': {'bp': 119629.0, 'sum': 248039.0}, '18_posi_8095': {'bp': 119453.0, 'sum': 273711.0}, '15_posi_7862': {'bp': 119422.0, 'sum': 290864.0}, '15_posi_8157': {'bp': 118745.0, 'sum': 265057.0}, '13_posi_8519': {'bp': 118133.0, 'sum': 239647.0}, '7_posi_8579': {'bp': 117738.0, 'sum': 249607.0}, '2_posi_8097': {'bp': 117565.0, 'sum': 268378.0}, '15_posi_7927': {'bp': 117553.0, 'sum': 228310.0}, '18_posi_8451': {'bp': 117503.0, 'sum': 234683.0}, '17_posi_8161': {'bp': 117282.0, 'sum': 272348.0}, 'ProcedureBlank_8032': {'bp': 117024.0, 'sum': 250096.0}, '1_posi_8268': {'bp': 116929.0, 'sum': 247642.0}, '17_posi_8390': {'bp': 116002.0, 'sum': 244953.0}, '2_posi_8015': {'bp': 115354.0, 'sum': 261748.0}, '18_posi_7993': {'bp': 115289.0, 'sum': 242798.0}, '15_posi_8517': {'bp': 115254.0, 'sum': 245461.0}, '14_posi_8096': {'bp': 115148.0, 'sum': 247226.0}, '2_posi_8537': {'bp': 115030.0, 'sum': 240553.0}, '18_posi_8389': {'bp': 114434.0, 'sum': 240655.0}, '16_posi_8095': {'bp': 113963.0, 'sum': 256755.0}, '11_posi_8415': {'bp': 113881.0, 'sum': 249897.0}, '15_posi_8074': {'bp': 113748.0, 'sum': 265309.0}, '17_posi_8241': {'bp': 113263.0, 'sum': 260884.0}, '12_posi_8498': {'bp': 112946.0, 'sum': 235827.0}, 'BLK02_7992': {'bp': 112670.0, 'sum': 247468.0}, '18_posi_8535': {'bp': 112648.0, 'sum': 229429.0}, '17_posi_8602': {'bp': 112530.0, 'sum': 257318.0}, '5_posi_8141': {'bp': 112235.0, 'sum': 240450.0}, '10_posi_7971': {'bp': 112128.0, 'sum': 225203.0}, '14_posi_8535': {'bp': 111858.0, 'sum': 245946.0}, '19_posi_8285': {'bp': 111796.0, 'sum': 265889.0}, '2_posi_8207': {'bp': 111204.0, 'sum': 230674.0}, 'ProcedureBlank_8499': {'bp': 110981.0, 'sum': 246356.0}, 'ProcedureBlank_8328': {'bp': 110538.0, 'sum': 241950.0}, '8_posi_8249': {'bp': 110311.0, 'sum': 259001.0}, '9_posi_8181': {'bp': 109780.0, 'sum': 254579.0}, '19_posi_8200': {'bp': 109674.0, 'sum': 255527.0}, '13_posi_7932': {'bp': 109578.0, 'sum': 241576.0}, '9_posi_8496': {'bp': 109369.0, 'sum': 260444.0}, '17_posi_8036': {'bp': 109229.0, 'sum': 252996.0}, '12_posi_8224': {'bp': 108862.0, 'sum': 245598.0}, '16_posi_8517': {'bp': 108757.0, 'sum': 262622.0}, '12_posi_8081': {'bp': 107669.0, 'sum': 237921.0}, 'BLK02_8370': {'bp': 107454.0, 'sum': 236446.0}, '8_posi_8498': {'bp': 107449.0, 'sum': 216014.0}, '14_posi_8250': {'bp': 107193.0, 'sum': 229585.0}, '13_posi_8057': {'bp': 107180.0, 'sum': 241854.0}, '11_posi_8286': {'bp': 106019.0, 'sum': 254999.0}, 'ProcedureBlank_8143': {'bp': 105780.0, 'sum': 247816.0}, '6_posi_8535': {'bp': 105727.0, 'sum': 250051.0}, '14_posi_7951': {'bp': 105616.0, 'sum': 230849.0}, '12_posi_8392': {'bp': 105573.0, 'sum': 237739.0}, '6_posi_8015': {'bp': 105545.0, 'sum': 229923.0}, '1_posi_7988': {'bp': 105479.0, 'sum': 229074.0}, '15_posi_8305': {'bp': 104912.0, 'sum': 225078.0}, '7_posi_8225': {'bp': 104759.0, 'sum': 244584.0}, '14_posi_8454': {'bp': 104579.0, 'sum': 231476.0}, '2_posi_8414': {'bp': 104543.0, 'sum': 233254.0}, '10_posi_7890': {'bp': 104065.0, 'sum': 235086.0}, '3_posi_8538': {'bp': 103893.0, 'sum': 231466.0}, '18_posi_8245': {'bp': 103174.0, 'sum': 212565.0}, 'BLK02_8581': {'bp': 102688.0, 'sum': 216810.0}, '3_posi_7991': {'bp': 102268.0, 'sum': 227465.0}, '15_posi_8453': {'bp': 101291.0, 'sum': 236875.0}, '4_posi_8538': {'bp': 101169.0, 'sum': 239304.0}, '1_posi_8492': {'bp': 100720.0, 'sum': 217179.0}, '8_posi_8014': {'bp': 100322.0, 'sum': 211081.0}, '14_posi_8347': {'bp': 99667.0, 'sum': 214161.0}, '13_posi_8246': {'bp': 98917.0, 'sum': 246336.0}, '13_posi_8350': {'bp': 98544.0, 'sum': 228792.0}, 'BLK02_8477': {'bp': 98528.0, 'sum': 215039.0}, 'ProcedureBlank_7870': {'bp': 97641.0, 'sum': 201087.0}, '15_posi_8243': {'bp': 97113.0, 'sum': 221064.0}, '10_posi_8330': {'bp': 93032.0, 'sum': 217750.0}, '6_posi_8455': {'bp': 89399.0, 'sum': 204323.0}}
COMMENT: RETENTION_TIME_STDEV 0.459
COMMENT: PRECURSOR_M/Z_RAW 153.113083
COMMENT: PRECURSOR_M/Z_STDEV 0.000049
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.322; C7H12N4; [M+H]+; delta(ppm) -0.322143
COMMENT: PROPOSED_MF MS-FINDER 2.601; C7H12N4; [M+H]+; delta(ppm) -0.325538
COMMENT: PROPOSED_MF SIRIUS5_Sirius 5.777; C7H12N4; [M+H]+; delta(ppm) -0.325538
COMMENT: PROPOSED_MF SIRIUS5_Sirius -2.420; C9H14NO; [M+H]+; delta(ppm) -9.094534
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H12N4; [M+H]+; delta(ppm) -0.325538
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.021; C7H12N4; [M+H]+; delta(ppm) -0.325538
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.266; C4H13FN4O; [M+H]+; delta(ppm) -7.788272
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.573; C9H14NO; [M+H]+; delta(ppm) -9.094534
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.675; C3H15N5P; [M+H]+; delta(ppm) -2.344318
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H12N4; [M+H]+; delta(ppm) -0.325538
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.913; KYAGGLONXREQED-UHFFFAOYSA-N; [M+H]+; 3-ethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.726; RWSWNQOCJVPCMF-UHFFFAOYSA-N; [M+H]+; 5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.475; RMTCWOLYVMOKBR-UHFFFAOYSA-N; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.454; SAYXVILDUZLWGX-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.214; FHYDQGOVTLQZSZ-UHFFFAOYSA-N; [M+H]+; N'-pyrimidin-2-ylpropane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.195; MHMOUFDAKNJXSK-UHFFFAOYSA-N; [M+H]+; 1-(1H-imidazol-2-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.111; KFJYLCFNRATSPE-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.031; ASGQRNXDYZQNPS-UHFFFAOYSA-N; [M+H]+; 4-(triazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; DAAKLDCBWHWWNI-RMKNXTFCSA-N; [M+H]+; N-methyl-N-[(E)-(1-methylimidazol-2-yl)methylideneamino]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.891; QDEKQIPSPLAOPI-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.872; SANLPMMCLNQJPP-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-5-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.841; OQHDZWPNEOFLCW-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.829; FILWPDPGRBPZDL-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.820; YPPVPNFMCXRUCC-UHFFFAOYSA-N; [M+H]+; 4-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.784; GMVWRTAXMQPIBG-UHFFFAOYSA-N; [M+H]+; 5-(1-aminoethyl)-4-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.766; GFUMZGPBCAJZHH-UHFFFAOYSA-N; [M+H]+; 2-(4-cyclopropyltriazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.757; KHDBXRADZIIFBK-UHFFFAOYSA-N; [M+H]+; 2-(1-cyclopropyltriazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.757; JBICIOACIKMMJM-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-N,N-dimethylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.748; QFOSWZIUPHQBRK-UHFFFAOYSA-N; [M+H]+; 8-methyl-2,3,6,7-tetrahydroimidazo[1,2-a]pyrimidin-5-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.746; JUYYERAJUGNAKT-UHFFFAOYSA-N; [M+H]+; 2-(3-cyclopropyl-1,2,4-triazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.741; GESFEOZCDXMGFO-UHFFFAOYSA-N; [M+H]+; 2-(6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.739; MSQSNZKVWZTSDJ-UHFFFAOYSA-N; [M+H]+; 2-(4-cyclopropyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.735; DLVUEWDMHXYYAO-UHFFFAOYSA-N; [M+H]+; 2-(3-cyclopropyl-1H-1,2,4-triazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.730; IMQGJTWGILNPMZ-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.699; WJXSFSALUZCCJQ-UHFFFAOYSA-N; [M+H]+; 3,8-dimethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.675; ZEFRABOWIHXNKA-UHFFFAOYSA-N; [M+H]+; 3-methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-d][1,4]diazepine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.674; IFPQNVUJBNWAGL-UHFFFAOYSA-N; [M+H]+; 2-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.664; XNHWFJRPVBJRPR-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.657; LGIWBPLJDKOQSX-UHFFFAOYSA-N; [M+H]+; 4-(2H-triazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.654; KGXBEJFERUBKKY-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.649; FYKDYYGNYLGWCA-UHFFFAOYSA-N; [M+H]+; 2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.642; KNGLSUWCXOCEKZ-UHFFFAOYSA-N; [M+H]+; 3-methyl-4,5,6,7-tetrahydrobenzotriazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.640; KGLMRCGIKAKFCH-UHFFFAOYSA-N; [M+H]+; 3-(triazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.640; MJIWVLBPVFCYJB-ZETCQYMHSA-N; [M+H]+; 1-[[(2S)-pyrrolidin-2-yl]methyl]triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.639; OIZMGVQEOVIMOL-UHFFFAOYSA-N; [M+H]+; 4-methyl-3-pyrrolidin-3-yl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.635; BXSGLNRNBMUCIM-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.630; AGIXGQFDUZRXCT-UHFFFAOYSA-N; [M+H]+; 1-(pyrrolidin-2-ylmethyl)-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.629; URSHNSSBVLGWNY-UHFFFAOYSA-N; [M+H]+; 1-methyl-4,5,6,7-tetrahydrobenzotriazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.629; YRQUFBNVMMTCEX-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.629; UOGYOJNDIFVZLJ-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.629; QCAHQEGOYONBHI-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.629; NMHSRADHFBXGAG-UHFFFAOYSA-N; [M+H]+; 6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.627; GREJTVKJTDGUQI-UHFFFAOYSA-N; [M+H]+; 2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.625; XMNCTKKZAFGKBV-UHFFFAOYSA-N; [M+H]+; 5-pyrrolidin-3-yl-1H-pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.625; XDUNSNMMXUKPIN-ZCFIWIBFSA-N; [M+H]+; 4-methyl-3-[(2R)-pyrrolidin-2-yl]-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.625; NYWMQSMKGVCQED-LURJTMIESA-N; [M+H]+; 3-methyl-5-[(2S)-pyrrolidin-2-yl]-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.618; IZHAMQUVVWJULL-UHFFFAOYSA-N; [M+H]+; 3-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.617; HSBDIERXOJWHKI-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-ylmethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.607; FNMXKIOFMCGDMH-UHFFFAOYSA-N; [M+H]+; (5-cyclopropyl-2-methyl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.604; PWQFWTMOGJDMLO-UHFFFAOYSA-N; [M+H]+; [3-(1,2,4-triazol-1-yl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.590; KELKBKXPSNKQRJ-UHFFFAOYSA-N; [M+H]+; [1-(cyclopropylmethyl)triazol-4-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.585; KLDLJJRSWZYEFL-UHFFFAOYSA-N; [M+H]+; 6,6-dimethyl-4,5-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.577; COBJBBVQXYDCJU-UHFFFAOYSA-N; [M+H]+; N-[(1-methyltriazol-4-yl)methyl]cyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.558; DKRJNDYSGMPAAB-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.557; NNTDOOSCXNZOBK-UHFFFAOYSA-N; [M+H]+; 5-cyclopentyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.544; PWEGFMVXXGYUTH-UHFFFAOYSA-N; [M+H]+; 4-N-propan-2-ylpyrimidine-4,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.535; OEURBUBEWIXBKU-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-ylmethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.473; VFXLTLDREFAZCG-UHFFFAOYSA-N; [M+H]+; [3-(triazol-1-yl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.312; HWXAKUICDBKUDB-UHFFFAOYSA-N; [M+H]+; 4-azidobicyclo[2.2.1]heptan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.491; RWSWNQOCJVPCMF; [M+H]+; 5-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.678; RMTCWOLYVMOKBR; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.629; COBJBBVQXYDCJU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -201.686; PWEGFMVXXGYUTH; [M+H]+; 4-N-propan-2-ylpyrimidine-4,5-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.061; DKRJNDYSGMPAAB; [M+H]+; 1,2,4-triazolo[4,5-a]piperidin-3-ylmethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -297.770; NNTDOOSCXNZOBK; [M+H]+; 5-cyclopentyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.060; RWSWNQOCJVPCMF; [M+H]+; 5-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -167.688; COBJBBVQXYDCJU; [M+H]+; N-((1-methyl-1H-1,2,3-triazol-4-yl)methyl)cyclopropanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -174.634; DKRJNDYSGMPAAB; [M+H]+; (5,6,7,8-Tetrahydro-[1,2,4]triazolo[4,3-A]pyridin-3-YL)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -178.221; RMTCWOLYVMOKBR; [M+H]+; N4,N4,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -180.023; RWSWNQOCJVPCMF; [M+H]+; 5-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -184.143; QDEKQIPSPLAOPI; [M+H]+; 2-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -199.157; YRQUFBNVMMTCEX; [M+H]+; 3-methyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -199.502; FHYDQGOVTLQZSZ; [M+H]+; N-(3-aminopropyl)pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.441; XNHWFJRPVBJRPR; [M+H]+; 3-methyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -209.587; FYKDYYGNYLGWCA; [M+H]+; (6R)-2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -213.975; YPPVPNFMCXRUCC; [M+H]+; 4-(4H-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.155; COBJBBVQXYDCJU; [M+H]+; N-((1-methyl-1H-1,2,3-triazol-4-yl)methyl)cyclopropanamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H13N4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 16.570
MS$FOCUSED_ION: PRECURSOR_M/Z 153.113423
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-2900000000-15c9b1994bc29e4c957a
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0445744 37.6196 69.045200 1.7525 8.88 0.1860 88 f{C3H5N2}/-2.18ppm,p-C4H8N2
  71.0603868 258.6541 71.061000 0.7036 27.19 0.4258 102 f{C3H7N2}/0.17ppm,p-C4H6N2
  83.0601613 87.3099 83.060665 1.1197 15.66 0.1815 102 f{C4H7N2}/-2.57ppm,p-C3H6N2
  85.0758507 71.0105 85.076330 1.5633 15.96 0.3006 102 f{C4H9N2}/-2.05ppm,p-C3H4N2
  110.0713035 168.9459 110.071530 1.1084 21.86 0.4873 102 f{C5H8N3}/0.27ppm,p-C2H5N1
  124.0868199 39.5560 124.086875 2.2726 8.98 0.1708 86 f{C6H10N3}/-0.84ppm,p-C1H3N1
  126.1023932 52.6756 126.102420 2.0935 12.10 0.1076 101 f{C6H12N3}/-1.43ppm,p-C1H1N1
  153.0656342 47.1716 153.065530 1.8685 10.76 -0.0005 88 ?
  153.0769642 55.3517 153.076860 2.0513 11.52 0.2426 99 ?
  153.1026042 79.8744 153.102500 1.5088 13.97 0.1988 102 ?
  153.1132392 999.0000 153.113135 0.5029 0.00 1.0000 102 f{C7H13N4}/-1.53ppm,p
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  69.044574 37.62 37
  71.060387 258.65 258
  83.060161 87.31 87
  85.075851 71.01 71
  110.071303 168.95 168
  124.086820 39.56 39
  126.102393 52.68 52
  153.065634 47.17 47
  153.076964 55.35 55
  153.102604 79.87 79
  153.113239 999.00 999
//
